Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03315208 · ClinicalTrials.gov registry record · NA
Study of a Transdiagnostic, Emotion-focused Group Intervention for Young Adults With Substance Use Disorders
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
NCT03315208: Completed NA study, sponsored by Massachusetts General Hospital.
NCT03315208 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 56 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03315208, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
Study Summary
The overall aim of this pilot study is to conduct a preliminary trial to evaluate the acceptability and feasibility of adding a transdiagnostic, emotion-focused group intervention (the Unified Protocol, UP) to treatment as usual (TAU) in a comprehensive outpatient program for adolescents and young adults with substance use disorders and emotional distress. Only patients seeking services or engaged in care at an existing outpatient program at MGH (the Addiction Recovery Management Service) are eligible for participation.
Interventions
- OTHER Treatment as Usual (TAU)
- BEHAVIORAL Unified Protocol (UP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2017-11-22 |
| Est. Completion | 2019-09-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03315208
The ClinicalTrials.gov registry entry for NCT03315208 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Treatment as Usual (TAU) is the first listed.
NCT03315208 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03315208 about?
NCT03315208 is a clinical study titled "Study of a Transdiagnostic, Emotion-focused Group Intervention for Young Adults With Substance Use Disorders". The overall aim of this pilot study is to conduct a preliminary trial to evaluate the acceptability and feasibility of adding a transdiagnostic, emotion-focused group intervention (the Unified Protocol, UP) to treatment as usual (TAU) in a comprehensive outpatient program for adolescents and young a...
What is the current status of trial NCT03315208?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2017-11-22. Estimated completion is 2019-09-20.
What interventions are being tested in trial NCT03315208?
The interventions under investigation include: Treatment as Usual (TAU) (OTHER), Unified Protocol (UP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03315208?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.